Toyota, Japan

Yuka Higuchi

This inventor holds 1 USPTO granted patent. Top assignee: Toyota Jidosha Kabushiki Kaisha. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuka Higuchi: Innovator in Biochemical Engineering

Introduction

Yuka Higuchi is a prominent inventor based in Toyota, Japan. She has made significant contributions to the field of biochemical engineering, particularly in the area of enzyme production. Her innovative work has led to the development of a valuable patent that enhances the production of essential biochemical compounds.

Latest Patents

Yuka Higuchi holds a patent for "Geranylgeranyl diphosphate synthase and DNA coding therefor." This patent involves the DNA coding for thermostable geranylgeranyl diphosphate (GGDP) synthase derived from Sulfolobus acidocaldarius. The DNA is instrumental in the production of GGDP synthase, which is crucial for the synthesis of GGDP, a compound with various applications in biochemistry.

Career Highlights

Yuka is currently employed at Toyota Jidosha Kabushiki Kaisha, where she continues to push the boundaries of innovation in her field. Her work has not only advanced the understanding of biochemical processes but has also contributed to the practical applications of these processes in various industries.

Collaborations

Yuka collaborates with esteemed colleagues such as Tokuzo Nishino and Shinichi Ohnuma. These partnerships enhance her research and development efforts, fostering an environment of innovation and creativity.

Conclusion

Yuka Higuchi's contributions to biochemical engineering exemplify the impact of innovative thinking in science and technology. Her patent and ongoing work at Toyota Jidosha Kabushiki Kaisha highlight her role as a leading inventor in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…